肝移植术毕动脉乳酸浓度可早期预测原发性移植物功能障碍
该单中心前瞻性数据库研究纳入2015–2016年296例肝移植受者,评估术毕动脉乳酸浓度(LCEOT)对早期移植物结局的预测价值。LCEOT≥5 mmol/L是预测原发性无功能(PNF)的最佳截断值,并可预测早期移植物功能障碍(EAD)及术后90天死亡,加入BAR评分后预测90天生存的AUC提升至0.87。
要点
- LCEOT≥5 mmol/L是预测PNF的最佳截断值(Se=83.3%,SP=74.3%)。
- LCEOT可预测PNF(P=0.02)和EAD(P=0.05)。
- LCEOT联合BAR评分可改善术后90天生存预测(AUC 0.87 vs 0.74)。
核心结论
- 术毕动脉乳酸浓度≥5 mmol/L是肝移植早期移植物结局的强预测因子。
主要发现
- LCEOT≥5 mmol/L预测PNF的敏感度83.3%、特异度74.3%、阳性似然比3.65、阴性似然比0.25、诊断比值比14.44。
- LCEOT≥5 mmol/L可预测PNF(P=0.02)、EAD(P=0.05)及术后90天内死亡(P=0.06)。
- LCEOT加入BAR评分后预测术后90天生存的AUC为0.87,优于BAR评分的0.74。
- LCEOT的预测价值在验证队列中得到确认。
临床怎么用
- 术毕动脉乳酸浓度≥5 mmol/L可用于识别PNF和EAD高风险受者,辅助术后早期决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although many prognostic factors of primary graft dysfunction after liver transplantation (LT) are available, it remains difficult to predict failure in a given recipient. OBJECTIVE: We aimed to determine whether the intraoperative assay of arterial lactate concentration at the end of LT (LCEOT) might constitute a reliable biological test to predict early outcomes [primary nonfunction (PNF), early graft dysfunction (EAD)]. METHODS: We reviewed data from a prospective database in a single center concerning patients transplanted between January 2015 and December 2016 (n = 296). RESULTS: There was no statistical imbalance between the training (year 2015) and validation groups (year 2016) for epidemiological and perioperative feature. Ten patients (3.4%) presented with PNF, and EAD occurred in 62 patients (20.9%); 9 patients died before postoperative day (POD) 90. LCEOT ≥5 mmol/L was the best cut-off point to predict PNF (Se=83.3%, SP=74.3%, positive likelihood ratio (LR+)=3.65, negative likelihood ratio (LR-)=0.25, diagnostic odds ratio (DOR)=14.44) and was predictive of PNF (P = 0.02), EAD (P = 0.05), and death ≤ POD90 (P = 0.06). Added to the validated BAR-score, LCEOT improved its predictive value regarding POD 90 survival with a better AUC (0.87) than BAR score (0.74). The predictive value of LCEOT was confirmed in the validation cohort. CONCLUSION: As a reflection of both hypoperfusion and tissue damage, the assay of arterial LCEOT ≥5 mmol/L appears to be a strong predictor of early graft outcomes and may be used as an endpoint in studies assessing the impact of perioperative management. Its accessibility and low cost could impose it as a reliable parameter to anticipate postoperative management and help clinicians for decision-making in the first PODs.
引用
- Golse N, Guglielmo N, El Metni A, et al. Arterial Lactate Concentration at the End of Liver Transplantation Is an Early Predictor of Primary Graft Dysfunction. Ann Surg. 2019. PMID: 29509585. doi:10.1097/SLA.0000000000002726
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。